COMP <GO>
HSIC vs MRK // FORWARD P/E MULTIPLE
Henry Schein Inc. (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: HSIC 3
— MRK 11
▲ FORWARD P/E MULTIPLE LEADER: MRK
LAST: $84.88 (-1.80%) • MKT CAP: $9.63B
forward-pe
21.4x
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
forward-pe
18.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HSIC VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HSIC | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 31.10% | 74.80% | -43.70 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.20% | 20.70% | -9.50 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.5x | 15.3x | -5.80 | HSIC | /valuation <GO> |
| Free Cash Flow Yield | 1.23% | 3.42% | -2.19 | MRK | /fcf-yield <GO> |
| Operating Margin | 5.00% | 34.30% | -29.30 | MRK | /operating-margins <GO> |
| Net Profit Margin | 3.20% | 28.10% | -24.90 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 4.00% | 1.30% | +2.70 | HSIC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.81 | 5.19 | -2.38 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.60% | -0.10 | HSIC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.8 | 56.9 | -9.06 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 0.92 | -0.03 | MRK | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 21.4x | 18.4x | +3.00 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.63B | $361.02B | -$351.39B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HSIC REV | MRK REV | HSIC GROSS % | MRK GROSS % | HSIC FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $13.18B | $65.01B | 31.1% | 74.8% | $118.7M | $12.36B |
| FY 2024 | $12.67B | $64.17B | 31.7% | 76.3% | $277.7M | $18.10B |
| FY 2023 | $12.34B | $60.12B | 44.0% | 44.0% | -$55.3M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HSIC // BETA 0.89
MRK // BETA 0.92